https://health.economictimes.indiatimes.com/news/pharma/usfda-grants-orphan-drug-designation-to-zydus-cadilas-saroglitazar-mg/80506195
Zydus Group: USFDA grants orphan drug designation to Zydus Cadila's Saroglitazar Mg, ETHealthworld
Zydus Group: Zydus Cadila, which is a part of Cadila Group, said orphan drug designation provides eligibility for certain development incentives, including tax...
orphan drug designation